Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cemtrex (CETXP) Cash & Equivalents (2016 - 2025)

Cemtrex's Cash & Equivalents history spans 16 years, with the latest figure at $20.5 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 385.44% year-over-year to $20.5 million; the TTM value through Dec 2025 reached $20.5 million, up 385.44%, while the annual FY2025 figure was $6.3 million, 17.1% up from the prior year.
  • Cash & Equivalents reached $20.5 million in Q4 2025 per CETXP's latest filing, up from $6.3 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $20.5 million in Q4 2025 to a low of $1.8 million in Q3 2021.
  • Average Cash & Equivalents over 5 years is $8.0 million, with a median of $6.5 million recorded in 2023.
  • Peak YoY movement for Cash & Equivalents: soared 552.16% in 2022, then plummeted 56.04% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $10.3 million in 2021, then tumbled by 44.21% to $5.8 million in 2022, then plummeted by 30.37% to $4.0 million in 2023, then increased by 5.16% to $4.2 million in 2024, then surged by 385.44% to $20.5 million in 2025.
  • Per Business Quant, the three most recent readings for CETXP's Cash & Equivalents are $20.5 million (Q4 2025), $6.3 million (Q3 2025), and $7.0 million (Q2 2025).